Bellus Health
BLU-X
3 watching
Join the Discussion
Comment Now
0
0
0
0
0
Your ReactionSignal
Opinion
Expert
SPECULATIVE BUY
SPECULATIVE BUY
March 18, 2019
The outlook is still quite good. People who use their competing chronic cough treatment lose their sense of taste. They are applying now for their drug's use for other conditions.
The outlook is still quite good. People who use their competing chronic cough treatment lose their sense of taste. They are applying now for their drug's use for other conditions.
biotechnology/pharmaceutical
SPECULATIVE BUY
SPECULATIVE BUY
January 16, 2019
A pharma company working on a new drug for chronic cough. Early testing has produced good effectiveness and no nasty side effects. Tests should be completed within the year. He believes 60 to 300 patients are being tested. They have great potential. A speculative buy. It may become a takeover target.
A pharma company working on a new drug for chronic cough. Early testing has produced good effectiveness and no nasty side effects. Tests should be completed within the year. He believes 60 to 300 patients are being tested. They have great potential. A speculative buy. It may become a takeover target.
biotechnology/pharmaceutical
Comments
Showing 1 to 2 of 2 entries
- «
- ‹
- 1
- ›
- »
00000
© Stockchase Inc.
Stock saved to your watch list successfully.View Watch List
